Skip to main content
. 2023 Sep 4;16(12):2683–2692. doi: 10.1093/ckj/sfad221

Figure 3:

Figure 3:

Proposed algorithm for thromboembolism prevention in hemodialysis patients with atrial fibrillation. Good OAT: patients taking VKA with TTR ≥65% or patients taking DOAC (off-label situation in Europe); Poor OAT: patients taking VKA with TTR <65% or patients not taking OAT; DOAC: direct oral anticoagulant; OAT: oral anticoagulant therapy; TTR: time in therapeutic range; VKA: vitamin K antagonist.